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THE ROLE OF SERUM CALCIUM, MAGNESIUM AND 
ZINC IN PREGNANCY INDUCED HYPERTENSION
Abstract:
Aim and Objective: 
Pregnancy  induced  hypertension  or  preeclampsia  is  triad  of 
hypertension, proteinuria and edema occurring after 20 weeks of gestation in 
previously  normotensive  women.  It  is  the  most  common  medical 
complication of pregnancy with incidence of 5% to 10% with increased in 
maternal  and  infant  mortality  and  morbidity.  The  exact  etiology  is  not 
known although various elements might play a role in preeclampsia.
The aim of the study is to analyze and compare the concentration of serum 
calcium,  magnesium and  zinc  level  in  women  with  preeclampsia  and  in 
normal pregnant women.
Materials and Methods:
This is a cross sectional case-control study involving 25 women with 
pre-eclampsia  in  case  group  and  25  normal  pregnant  women  in  control 
group.  The  inclusion  criteria  for  case  group  were  age  group in  between 
20-40  yrs  including  both  primi  and  second  gravida  in  third  trimester  of 
pregnancy  (>24  weeks  of  pregnancy).  The  blood  pressure  measured  by 
sphygmomanometer in upper arm in sitting posture was ≥140/90mmHg in 
two different occasions taken 6 hours apart. The urine albumin was ≥1+ or 
in the mid stream random sample of urine. The controls group was formed 
by 25 age matched normal pregnant women either primi or second gravida 
in  third  trimester  of  pregnancy.  The  patients  with medical  complications 
such as Diabetes Mellitus, renal failure, chronic hypertension, heart failure 
or ischaemic heart disease, multiple pregnancies, pregnancy < 24 weeks of 
gestation, patients on magnesium sulphate and calcium lactate therapy were 
excluded from the study.
The Body Mass Index (BMI), serum calcium, magnesium and zinc levels 
were compared between the case and control groups.
Results:
The  BMI  was  significantly  higher  in  preeclamptic  women  when 
compared  to  normal  pregnant  women  28.71±4.70  versus  22.46±3.42 
P<0.001. The serum calcium, magnesium and zinc levels in preeclamptic 
women were significantly lower when compared to normal pregnant women 
8.07±0.43 versus 8.96±0.59 P<0.001, 1.62±0.16 versus 1.92±0.16 p<0.001, 
80.7±9.78 versus 93.28±9.44 for cases and controls respectively.
Conclusion: 
Although  the  calcium,  magnesium  and  zinc  deficiency  cannot  be 
pinpointed as the sole factors for the etiology of preeclampsia, they have a 
definite role in the development of preeclampsia.
Key words: Preeclampsia,  serum calcium,  serum magnesium and  serum 
Zinc.
INTRODUCTION
Nutritional  deficiencies  are  common  during  pregnancy. 
Pregnant women in the developing countries have been reported 
to consume diets that are low in minerals and vitamins Begum et  
al., 2000.  An  inadequate  dietary  intake  before  and  during 
pregnancy might be a risk not only for the mother but also for the 
fetus. Deficiency of the elements such as magnesium, zinc have 
been implicated in the pregnancy wastage, congenital anomalies, 
pregnancy  induced  hypertension,  placental  abruption  of 
membrane, low birth weight and still births Hofmeyr et al., 2007.
On the physiological basis, calcium plays an important role 
in  muscle  contraction  and  the  modification  of  plasma  calcium 
concentration  leads  to  an  alteration  in  the  blood  pressure. 
Magnesium has  been known as  an  essential  cofactor  for  many 
enzyme  systems.  It  also  plays  an  important  role  in  the 
neurochemical transmission and peripheral vasodilatation. Zinc is 
required  for  the  DNA  replication,  transcription  and  cellular 
replication  as  it  is  the  metallic  component  of  various  related 
enzymes (i.e) DNA polymerase, RNA polymerase and thymidine 
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kinase. Essentiality of the zinc during pregnancy is evident. In the 
zinc deficient animals and women poor outcome of pregnancy is 
observed Carey et al., 2000.
Pregnancy  induced  hypertension  or  preeclampsia  is  a 
transient  but  potentially  dangerous  complication  of  pregnancy, 
with  worldwide  significance  to  the  mother  and  the  infants.  It 
affects  approximately  5-10%  of  the  pregnancies  world  wide 
Skjaervan  et al., 2002 and results in 15% of preterm deliveries 
and 14% of maternal deaths per year Belizan et al., 1983. In the 
developing countries,  preeclampsia  accounts  for  20-80% of  the 
strikingly increased maternal  mortality  Sarsam  et  al., 2008.  In 
India the incidence of preeclampsia is reported to be 8-10% of 
pregnancies.
Preeclampsia has been dubbed as the ‘Disease of  theories’ 
because  of  the  multiple  hypothesis  that  have  been proposed to 
explain its occurrence.  Although many pathophysiologic factors 
such as inflammation, cytokine production, dyslipidaemia  Hube, 
1998,  elevated  homocysteine  Laivuori et  al., 1999,  oxidative 
stress  Roberts  and  Hubel,  2004,  reduced  calcium  intake  and 
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excretion  and  an  imbalance  between  the  thromboxane  and 
prostacyclin  Paknahad  et al., 2008  have been implicated in the 
etiology of preeclampsia, the complete etiologies have not been 
fully elucidated Golmohammad et al., 2008.    
Although  the  high  rate  of  preeclampsia  in  developing 
countries has forced some authors to propose the involvement of 
the nutrition, especially the trace elements in the etiology of the 
disorder Caughey et al., 2005 studies on the relationship between 
the  maternal  serum  trace  elements  concentrations  and  the 
preeclampsia  have  produced  inconsistent  results  Harma  et  al., 
2005.
Hence this study is taken up to analyze and to compare the 
concentrations of calcium, magnesium and zinc in the serum of 
women with preeclampsia and in the normal pregnant women and 
to evaluate their role in the pregnancy induced hypertension.
It is hoped that this study will contribute to the knowledge of 
the  role  of  serum  calcium,  magnesium  and  zinc  in  pregnancy 
induced hypertension.
9
AIM AND OBJECTIVES
This study involves
1) The estimation of serum calcium, magnesium and zinc 
levels in preeclamptic women in their third trimester of 
pregnancy as patients group.
2) The estimation of the serum calcium, magnesium and 
zinc  levels  in  age  matched  healthy  normotensive 
pregnant women in third trimester as control group.
3) Comparison  of  concentration  of  calcium,  magnesium 
and  zinc  in  the  serum  between  the  patient  and  the 
control group.
4) To evaluate the role of calcium, magnesium and zinc in 
pregnancy induced hypertension.
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REVIEW OF LITERATURE
PREGNANCY INDUCED HYPERTENSION
Pregnancy  induced  hypertension  or  preeclampsia  is  a 
multisystem  disorder  of  unknown  etiology  characterized  by 
development of hypertension to the extent of  140/90 mmHg or 
more with proteinuria after 20 weeks of pregnancy in previously 
normal and non-proteinuric patient. 
Historical aspects:
The fact  that  some pregnant  women had epileptiform fits 
was known to Hippocrates, who lived in the fourth century BC. 
The condition was called eclampsia, although the word does not 
refer to fits. The original Greek word meant flash out, in the sense 
of sudden event.  Little more was known about eclampsia,  until 
John Lever in 1843 found that many of the women who had fits 
also had albumin in their urine. However, it was not until early in 
this century, when the sphygmomanometer was introduced, it was 
recognized  that  eclampsia  was  associated  with  hypertension, 
which could precede the onset of fits, give rise to the concept of 
preeclampsia as a clinical condition.
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For many years it was postulated that toxins was liberated 
from  the  pregnant  uterus  and  the  disorder  became  known  as 
toxemia  of  pregnancy.  All  efforts  have  so  far  failed  to 
demonstrate any such toxin and the word toxemia is now avoided.
The Placenta:
Historical aspects:
The placenta was already recognized and venerated by early 
Egyptians,  while  it  was  the  Greek  physician  Diogenes  of 
Apollonica (Ca.480 BC) who first ascribed the function of fetal 
nutrition of the organ.  Arsitolle (384-322 BC) described that the 
fetus  is  fully  enclosed  within  the  membranes  and  it  was  only 
during the  Renaisance that the term placenta, the word derived 
from the  Latin  root  meaning a  “flat  cake” was  introduced by 
Realdus Colombus in 1559.
Placental organization:
The  term  hemochorial is  used  to  describe  human 
placentation. It derives from hemo referring to the maternal blood, 
which directly  baths the  syncytiotrophoblast  and the  chorio for 
chorion (Placenta).
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Chorionic villi:  
Approximately on the 12th day after fertilization chorionic 
villi can first be distinguished. Mesenchymal cords derived from 
the  extraembryonic  mesoderm invade  the  solid  trophoblast  and 
this  forms  secondary  villi.  After  angiogenesis  begins  in  the 
mesenchymal cords, the resulting villi are termed as tertiary villi.
Villi are covered by the outer layer of syncytium and inner 
layer  of  cytotrophoblast,  which  are  known as  Langhans  cells. 
Cytotrophoblast  proliferation  at  the  villi  tips  produces  the 
trophoblastic cell columns that form anchoring villi.
Placental development:
Development of chorion and decidua:
In early pregnancy, the villi are distributed over the entire 
periphery  of  chorionic  membrane.  As  the  blastocyst  with  its 
surrounding trophoblasts grows and expands into the decidua, one 
pole  extends  outwards  towards  the  endometrial  cavity.  The 
opposite pole will form the placenta from villous trophoblasts and 
anchoring  cytotrophoblast.  Chorionic  villi  in  contact  with  the 
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decidua  basalis  proliferate  to  form  the  chorionic  frondosum, 
which is the fetal component of the placenta.
Maternal regulation of trophoblast invasion and the vascular 
growth:
Decidual  natural  killer  cells  accumulate  in  the  decidua 
during  the  first  half  of  the  pregnancy  and  are  found  in  direct 
contact  with  the  trophoblast.  These  cells  lack  the  cytotoxic 
functions as well as other unique properties that distinguish them 
from circulating natural killer cells. This is important because it 
prevents them from recognizing and destroying the fetal cells as 
“foreign”. The decidual natural killer cells attract and promote the 
invasion  of  trophoblast  into  decidua  and  promote  the  vascular 
growth  Hana  and  associate  2006.  The  Decidual  natural  killer 
cells  express  both  interleukin-8 and  interferon  inducible 
protein-10, which binds to receptors on invasive trophoblast, cells 
to  promote  their  invasion  into  decidua  towards  spiral  arteries. 
Decidual  natural  killer  cells  also produce proangiogenic  factors 
including the vascular endothelial growth factor (VEGF) and the 
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placental growth factor (PGF), which promote vascular growth in 
decidua.
Trophoblast invasion of endometrium:
The  extravillious  trophoblasts  are  highly  invasive.  They 
form columns of cells that extend from the endometrium to the 
inner third of myometrium. The invasive ability of trophoblasts 
results from their ability to secrete numerous proteolytic enzymes 
capable of digesting the extracellullar matrix as well as activating 
proteinases  already  present  in  the  endometrium.  Trophoblasts 
produce urokinase type plasminogen activator, which converts the 
plasminogen into the broadly acting serine protease plasmin. This 
in  turn  both  degrades  mature  proteins  and  activates  matrix 
metalloproteinases  (MMPs),  which  are  a  family  of  structurally 
similar  enzymes.  One  member  of  the  family,  Matrix 
metalloproteinase-9 (MMP-9), appears to be critical for the human 
trophoblast  invasion.  MMP-9  production  is  increased  by  the 
trophoblast  factors  such as  IL-1 and hCG as well  as  paracrine 
uterine  factors  such  as  leukemia  inhibiting  factor  and  colony-
stimulating factor-1 Bischof, 2009.
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Invasion of spiral arteries:
One  of  the  most  remarkable  features  of  human placental 
development is the extensive modification of maternal vasculature 
by trophoblasts. Modifications of spiral arteries are carried out by 
two  populations  of  extravillous  trophoblast  (i)  interstitial 
trophoblast  that  surrounds  the  arteries  and  (ii)  endovascular 
trophoblast,  which penetrate  the spiral  arterial  lumen.  Although 
earlier work has focused on the role of endovascular trophoblast, 
function  of  interstial  trophoblast  has  more  recently  been 
investigated Pijnenborg and colleague, 1983.
Endovascular trophoblast enters the lumen of spiral arteries 
and initially  forms  the  cellular  plugs.  It  then  destroys vascular 
endothelium  via  an  apoptosis  mechanism,  which  invades  and 
modifies the vascular media. Thus the fibrinoid material replaces 
smooth muscle and connective tissue of the vascular media. The 
spiral artery later regenerates the endothelium.
The development of the uteroplacental vessels proceeds in 
two  waves  of  stages.  The  first  occurs  before  12th weeks  post 
fertilization and consists of invasion and modification of the spiral 
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arteries  upto the  border  between decidua and the  myometrium. 
The second wave is  between 12th and  16th weeks  and involves 
some invasion of intra myometrial segments of the spiral arteries. 
The remodelling by this two-phase invasion converts the narrow 
lumen  muscular  spiral  arteries  into  dilated,  low  resistance 
uteroplacental vessels.
Placental growth:
In the first  trimester,  placental  growth is more rapid than 
that  of  the  fetus.  By  approximately  17th postmenstrual  weeks, 
placenta and fetal weight are almost equal. By term, the placental 
weight is about one sixth of the fetal weight. The average placenta 
at  term is  185mm in  diameter  and 23mm in  thickness,  with  a 
volume  of  497  ml  and  weight  of  508  gm.  Viewed  from  the 
maternal surface,  the number of  slightly elevated convex areas, 
called  lobes varies  from  10  to  38  William  Obstetrics  23rd 
edition.  The total  number  of  placental  lobes  remains  the  same 
throughout  gestation  and  individual  lobes  continue  to  grow 
although less actively at term Crawford, 1959.
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Terminology and Classification:
The  working  group  of  National  High  Blood  Pressure 
Education  Program  NHBPEP  (2000) classification  of 
hypertensive disorder complicating pregnancy is 
1) Gestational hypertension
2) Preeclampsia and eclampsia syndrome
3) Preeclampsia  syndrome  superimposed  on  chronic 
hypertension and
4) Chronic hypertension.
1) Gestational hypertension: 
• Systolic BP ≥ 140 or diastolic BP ≥ 90 mmHg for the first 
time during pregnancy. 
• No proteinuria. 
• BP returns to normal before 12 weeks post partum.
2) Preeclampsia and eclampsia syndrome: 
Preeclampsia: 
Minimum Criteria: 
• BP ≥ 140/90 mmHg after 20 weeks of gestation.
• Proteinuria ≥ 300mg/24 hrs or ≥ 1+ dipstick.
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Increased certainty of preeclampsia:
• BP ≥ 160/100 mmHg.
• Proteinuria 2.0gm/24 hrs or ≥ 2+ dipstick.
• Serum creatinine > 1.2mg/dl unless known to be previously 
elevated.
• Platelets < 100000/µl of blood.
• Microangiopathic  hemolysis  –  increased  lactate 
dehydrogenase (LDH).
• Elevated  serum  transaminase  level  –  alanine 
aminotransferase  (ALT)  or  aspartate  aminotransferase 
(AST).
• Persistent headache or other cerebral or visual disturbance.
• Persistent epigastric pain.
Eclampsia:
• Seizure that cannot be attributed to other causes in women 
with preeclampsia.
3) Superimposed preeclampsia on chronic hypertension:
• New-onset  proteinuria  ≥  300mg/24hrs  in  hypertensive 
women but no proteinuria before 20 weeks gestation.
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• A  sudden  increase  in  proteinuria  or  blood  pressure  or 
platelet count < 100000/µl in women with hypertension and 
proteinuria before 20 weeks gestation.
4) Chronic hypertension:
• BP ≥ 140/90 mmHg before pregnancy or diagnosed before 
20  weeks  gestation  not  attributable  to  gestational 
trophoblastic disease. 
(Or)
• Hypertension first diagnosed after 20 weeks gestation and 
persistent after 12 weeks post partum.
Etiology:
Preeclamsia as a two-stage disorder:
Observations that the abnormal interfaces between maternal, 
paternal  and  fetal  tissues  may  cause  preeclampsia  have  led  to 
hypotheses  that  the  syndrome  is  a  two stage  disorders.  In  this 
scenario, there is a spectrum to include “Maternal and Placental 
preeclampsia” Ness and Roberts, 1996.
Stage 1 is caused by the faulty endovascular trophoblastic 
remodelling  that  downstream  causes  the  stage  2  clinical 
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syndrome. Importantly, stage 2 is susceptible to modification by 
the preexisting maternal condition that includes cardiac or renal 
diseases, diabetes, obesity or hereditary influences.
Abnormal trophoblastic invasion:
In  the  normal  implantation,  the  uterine  spiral  arterioles 
undergo  extensive  remodelling  as  they  are  invaded  by 
endovascular  trophoblast.  These  cells  replace  the  vascular 
endothelial and muscular linings to enlarge the vessel diameter. 
The veins are invaded only superficially in preeclampsia, which 
may be due to an incomplete trophoblastic invasion. The deeper 
myometrial  arterioles  do  not  lose  their  endothelial  lining  and 
muscular elastic tissue, their mean external diameter is only half 
that  of  vessels  in  normal  placenta.  The magnitude of  defective 
trophoblastic invasion of the spiral arteries correlates with severity 
of the hypertension disorder Madazli  and associates, 2000.  De 
wolf  and  co-workers,  1980 examined  arteries  taken  from 
implantation  site  and  reported  that  early  preeclamptic  changes 
included  endothelial  damage,  insudation  of  plasma  constituents 
into  vessel  walls,  proliferation  of  myointimal  cells  and  medial 
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necrosis.  Lipid  accumulated  first  in  myointimal  cells  and  then 
within  macrophages.  Lipid  laden  cells  and  associated  findings 
referred as atherosis by Hertig, 1945. 
Immunological factors
Loss of maternal immune tolerance to the paternally derived 
placenta and fetal antigen and its dysregulation is another theory 
cited to account for preeclampsia syndrome. It has been proposed 
that  endothelial  cell  dysfunction is  due to an extreme activated 
state of leucocyte in maternal circulation Faas, 2000.
Nutritional factors:
In general  population, a diet  high in fruits and vegetables 
that have antioxidant activity is associated with decrease in blood 
pressure  John  and  co-workers  2002.  The  incidence  of 
preeclampsia  was  doubled  in  women  whose  daily  intake  of 
ascorbic acid was less than 85 mg Zhang and associates 2002.
Genetic factors:
Preeclampsia  is  a  multifactorial,  polygenic  disorder. 
Incident  risk  of  preeclampsia  is  20-40%  of  daughter  of 
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preeclamptic mothers, 11-37% for sisters of preeclamptic women 
and 20-47% in twin studies Wang et al., 2002.
Pathophysiology:
Vasospasm:
In  preeclampsia  the  blood  vessels  throughout  the  body 
undergo vasoconstriction. The constricted segments contribute to 
the heightened peripheral resistance and hence hypertension. At 
the  same  time,  the  endothelial  cell  damage  cause  interstitial 
leakage through which blood constituents including platelets and 
fibrinogen are deposited subendothelially. With diminished blood 
flow  because  of  maldistribution,  ischaemia  of  the  surrounding 
tissue  would  lead to  necrosis,  hemorrhage  and other  end-organ 
disturbances  characteristic  of  the  syndrome  Suzuki  and  co-
workers 2003.
Endothelial cell activation:
The clinical syndrome of preeclampsia is thought to result 
from  these  widespread  endothelial  cell  changes.  Circulating 
endothelial cell CEC levels are significantly elevated fourfold in 
the  peripheral  blood of  preeclamptic  women  Grundmann and 
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associates  2008.  Damaged  or  activated  endothelial  cell  may 
produce  less  nitric  oxide  and  secrete  substances  that  promote 
coagulation and increased sensitivity to vasopressors.  
Increased pressor response:
The  pregnant  women  normally  develop  refractoriness  to 
infused vasopressors.  Women with early preeclampsia,  however 
have increased vascular reactivity to infused norepinephrine and 
angiotensin  II.  Normotensive  nulliparas  remain  refractory  to 
infused  angiotensin  II  but  those  who  subsequently  become 
hypertensive lost this refractoriness several weeks before the onset 
of hypertension.
Prostaglandins:
A number of  prostanoids are thought  to be central  to the 
pathophysiology of the preeclampsia syndrome. Specifically, the 
blunted  pressor  response  seen  in  normal  pregnancy  is  atleast 
partially due to the decreased vascular responsiveness mediated by 
the  endothelial  prostaglandin  synthesis.  The  endothelial 
prostacyclin (PGI2) production is decreased in preeclampsia. This 
action  is  mediated  by  phospholipase  A2.  At  the  same  time 
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thromboxane  A2 secretion  by  platelet  is  increased  and 
prostocyclin  :  thromboxane  A2 ratio  decreases.  The  net  result 
favour  increased  sensitivity  to  infused  angiotensin  II  and 
ultimately vasoconstriction Spitz and colleagues, 1988.
Nitric oxide:
The potent vasodilator is synthesized from L-arginine by the 
endothelial cells. Withdrawal of nitric oxide results in a clinical 
picture  similar  to  preeclampsia  in  a  pregnant  animal  model.  In 
human,  nitric  oxide is  the compound that  maintains the normal 
low  pressure,  vasodilated  state  characteristic  of  fetoplacental 
perfusion.
Endothelins:
These 21 amino acid peptides are potent vasoconstrictors, 
and endothelin-1 (ET-1) is the primary isoform produced by the 
human  endothelium.  Plasma  ET-1  levels  are  increased  in 
normotensive  pregnant  women  but  women  with  preeclampsia 
have higher levels  Ajne, 2003. The placenta is not the source of 
increased ET-1 concentration and they likely arise from systemic 
endothelial activation. The treatment of preeclamptic women with 
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magnesium  sulphate  lowers  ET-1  concentration  Sagsoz  and 
Kucukozkan 2003.
Angiogenic and antiangiogenic proteins:
Placental  vasculogensis  is  evident  by  21  days  after 
conception.  There  are  many  pro  and anti  angiogenic  substance 
involved in placental vascular development. In preeclampsia there 
exists  an  angiogenic  imbalance  with  excessive  amounts  of 
antiangiogenic  factors  are  hypothesized  to  be  stimulated  by 
worsening  of  hypoxia  at  the  uteroplacental  interface. 
Trophoblastic tissue of women destined to develop preeclampsia 
overproduces  atleast  two  antiangiogenic  peptides  that  enter 
maternal circulation.
1. Soluable Fms-like tyrosine kinase 1 (sFlt-1) is a variant of the 
Flt-1 receptor decreases the circulating free placental  growth 
factor (PGF) and vascular  endothelial  growth factor (VEGF) 
concentration leading to the endothelial dysfunction.
2. Soluble endoglin (sEng) is a placenta derived 65-kDa molecule 
is  a  co-receptor for  the TGF-β family.  This  soluble form of 
endoglin  inhibits  various  TGF-β isotopes  from  binding  to 
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endothelial receptors and results in decreased endothelial nitric 
oxide dependant vasodilatation Levine and co-workers 2006.
Although  the  cause  of  preeclampsia  still  remains  unknown, 
evidence  for  its  manifestation  begins  early  in  pregnancy  with 
covert  pathophysiological  changes  that  gain  momentum  across 
gestation  and  eventually  become  clinically  apparent.  Unless 
delivery supervenes, these changes ultimately results in the multi-
organ involvement that can be life threatening for both mother and 
fetus.
Changes in Maternal system:
The cardiovascular system:
Severe  disturbance  of  normal  cardiovascular  functions  in 
preeclampsia are related to
1) Increased cardiac afterload caused by hypertension.
2)  Cardiac  preload,  which  is  substantively  affected  by 
pathologically diminished hypervolemia of pregnancy.
3) Endothelial activation with extravasation of intravascular fluid 
into extracellular space and importantly into the lungs.
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Apart  from left  ventricular  mass  increase  in  normal  pregnancy 
there is no convincing evidence that additional structural changes 
are induced by preeclampsia.
The Blood volume:
In preeclamptic women the normally expected hypervolemia 
is severely curtailed and in some women, even absent  Zeeman 
and colleague,  2009.  The women of  average  size  should  have 
blood volume nearly 5000ml during last several weeks of normal 
pregnancy  compared  with  approximately  3500ml  of  when  not 
pregnant.  With  preeclampsia  however  much  or  all  of  the 
anticipated normal excess 1500ml is lost. Such hemoconcentration 
results from generalized vasoconstriction that follows endothelial 
activation and leakage of plasma into interstitial space because of 
increased permeability. Women with gestational hypertension but 
without preeclampsia, usually have a normal blood volume Silver 
and colleagues, 1998.
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The blood and coagulation:
Thrombocytopenia:
Thrombocytopenia  with  preeclampsia  has  been  described 
atleast since 1922 by Stancke. The frequency and the intensity of 
thrombocytopenia  vary  and  are  dependent  on  the  severity  and 
duration of preeclampsia syndrome. The overt thrombocytopenia 
defined by platelet count < 1,00,000/µl – indicates severe disease. 
In  general,  the  lower  the  platelets  count,  higher  the  rates  of 
maternal  and  fetal  morbidity  and  mortality  Leduc  and  co-
workers, 1992. In addition to thrombocytopenia the other platelet 
alteration include platelet activation with increased degranulation, 
thromboxane A2   release and decreased life span.
Hemolysis:
Severe preeclampsia is frequently accompanied by evidence 
of  hemolysis.  It  is  evidenced  by  elevated  serum  lactate 
dehydrogenase  levels  and  the  other  evidences  are  schizocytes, 
spherocytosis and reticulocytosis in peripheral blood.
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Coagulation:
There is increased factor VIII consumption, increased levels 
of fibrinopeptides A and B and of fibrin degradation products and 
decreased  levels  of  regulatory  proteins   antithrombin  III  and 
protein C and S.
The Endocrine changes:
Plasma levels of renin,  angiotensin II and aldosterone are 
substantively  increased  during  normal  pregnancy.  With 
preeclampsia,  despite  decreased  blood  volume,  these  values 
decreased substantively, but still remain above the non-pregnant 
values.
The Kidneys:
During  normal  pregnancy,  the  renal  blood  flow  and 
glomerular  filtration  rate  are  increased  appreciably.  With 
development  of  preeclampsia,  renal  perfusion  and filtration  are 
reduced. Mildly diminished glomerular filtration may result from 
reduced plasma volume. Most of the decrement is probably from 
increased renal afferent arteriolar resistance that may be elevated 
upto  five  fold.  The  morphological  changes  include  glomerular 
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endotheliosis, blocking the filtration barrier. Diminished filtration 
cause serum creatinine values to rise than the values seen in non 
pregnant individuals.  Plasma uric acid concentration is typically 
elevated in preeclampsia. This elevation is likely due to enhanced 
tubular  reabsorption  Chesley  and  Williams,  1945.  Another 
possibility  is  from  increased  placental  urate  production 
compensatory to increased oxidative stress.
Proteinuria:
At  least  some  degree  of  proteinuria  will  establish  the 
diagnosis of preeclampsia. Proteinuria may develop late and some 
women may be delivered or have an eclamptic convulsion before 
it  appears. 10-15 percent of women with HELLP syndrome did 
not  have  proteinuria  at  presentation.  17  percent  of  eclamptic 
women did not  have proteinuria  by the time of  seizures  Sibai, 
2004. 
Another problem is that the optimal method of establishing 
either abnormal levels of urine protein or albumin remains to be 
defined. The clean catch and catheterized urine specimen correlate 
well.  The  dipstick  qualitative  determinations  depend  on  the 
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urinary  concentration  and  notorious  for  the  false-positive  and 
negative  results.  There  are  several  methods  used  to  measure 
proteinuria, and none detect all of the various proteins normally 
excreted.  A  more  accurate  method  involves  measurement  of 
albumin  excretion.  Albumin  filtration  exceeds  that  of  larger 
globulins,  and  with  glomerular  disease  such  as  preeclampsia, 
much of the protein in the urine is albumin.
Finally,  although  the  worsening  proteinuria  has  been 
considered by most  to  be  sign of  severe  disease  the  quality  of 
protein alone as an indicator of preeclampsia severity is currently 
being investigated Airoldi and Weinstein, 2007.
Anatomical changes:
Glomeruli are enlarged by approximately 20 percent; they 
are  “bloodless”  and  capillary  loops  variably  dilated  and 
contracted.  Endothelial  cells  are  swollen,  and  this  was  termed 
glomerular  capillary  endotheliosis  by  Spargo  and  associates, 
1959.  Endothelial  cells  are  often so swollen that  they block or 
partially block the capillary lumens. Homogenous subendothelial 
deposits of proteins and fibrin-like material are seen. Rarely acute 
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tubular necrosis and acute renal failure develops in women with 
preeclampsia.
The Liver:
The characteristic lesions commonly found were regions of 
periportal hemorrhage in liver periphery. The microhemorrhages 
may then coalesce to give rise to a subcapsular hematoma. In rare 
instances,  the  hemorrhage  may  further  increase  to  cause  liver 
rupture and hemoperitoneum.
HELLP Syndrome:
HELLP is  an  acronym,  which  was  coined  by  Louis 
Weinstein 1892 denoting Hemolysis, Elevated liver enzymes and 
Low  platelets.  It  is  a  recognized  complication  of  severe 
preeclampsia  although at  times,  it  can  occur  in  the  absence  of 
hypertension  and  proteinuria.  It  occurs  in  0.2-0.6%  of  all 
pregnancies and 4-12% pregnancies complicated by preeclampsia 
Ian Donald, 6th edition.
The Nervous System:
The  cerebral  pathology  comprises  thrombosis,  fibrinoid 
necrosis of cerebral arterioles, diffuse microinfarcts and petechial 
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hemorrhages. Reversible foci of cerebral ischemia or oedema have 
also been identified on magnetic resonance imaging usually in the 
posterior  cerebral  circulation.  The  cause  for  the  cerebral 
dysfunction of preeclampsia is not known. The autopsy evidence 
that  the  problem  is  of  ischemia  secondary  to  intense 
vasoconstriction.
The visual changes:
Scotoma,  blurred  vision  or  diplopias  are  common  with 
severe preeclampsia. Blindness is less common, usually reversible 
and may arise from three potential areas. These are visual cortex 
of  occipital  lobe,  lateral  geniculate  nuclei  and retina.  In  retina, 
lesions may include ischemia, infarction and detachment. 
The Uteroplacental circulation:
Impairment  of  the  uteroplacental  circulation  affects  the 
placental  functions  that  sustain  the  fetus.  Preeclampsia  is 
considered  to  be  a  maternal  disorder  in  which  the  fetus  is  an 
incidental participant, but from the fetus’s point of view, it could 
be a fetal disorder in which the mother is an incidental participant 
Turnbull’s  Obstetrics  2nd edition.  It  is  a  placental  disorder, 
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which causes both maternal and fetal syndromes. Preeclampsia is 
an  important  cause  of  intrauterine  growth  retardation  in 
congenitally  normal  singletons.  Fetal  growth  failure  is  more  a 
feature of early onset disease.  Perinatal mortality increases once 
proteinuria  is  established.  About  three  quarters  of  the  excess 
mortality can be explained by overt placental pathology consistent 
with  the  view that  preeclampsia  is  a  primary  placental  disease 
Naeye & Friedman, 1979.
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THE CALCIUM
Introduction:
The calcium is the fifth most common elements in our body. 
Physiologically calcium is classified as either intracellular or extra 
cellular. The Intracellular calcium has many important functions 
including  muscle  contraction,  hormone  secretion,  glycogen 
metabolism and cell division. The extracellular calcium provides 
calcium ion  for  maintenance  of  the  intracellular  calcium,  bone 
mineralisation, blood coagulation and plasma membrane potential.
The  total  body  calcium  in  adult  human  is  1-2  Kg. The 
skeleton  contains  99%  of  body  calcium,  0.1%  of  total  body 
calcium is  in  the  extracellular  fluid.  1% of  calcium is  present 
inside  the  cells. In  blood  the  total  calcium  concentration  is 
normally 8.5 – 10.5 mg/dl (2.2 – 2.6 mmol/l) Harrison Principle 
of internal medicine 17th edition.
 The calcium in plasma present in three forms (1) About 
41% of calcium is combined with plasma proteins and in this form 
is  non-diffusible  through capillary membrane.  (2)  About  9% is 
diffusible through the capillary membrane but is combined with 
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anionic  substance  of  plasma  and  interstitial  fluids  (Citrate  & 
phosphate) in such manner that is is not ionized. (3) Remaining 
50% of calcium is diffusible through capillary membrane and is 
ionized Guyton and Hall 11th edition. 
The concentration of ionized calcium in extracellular fluid 
must be maintained within a narrow range because of the critical 
role it plays in wide array of cellular functions, especially those 
involved  in  neuromuscular  activity,  secretion  and  signal 
transduction.  Control  of  the  ionized  calcium  concentration  in 
extracellular  fluid  is  accomplished  by  adjusting  the  rates  of 
calcium movement across intestinal and renal epithelia. 
These adjustments are mediated mainly via changes in the 
blood  levels  of  hormones  parathyroid  hormone  and  1,25-
dihydroxycholecalciferol.  Blood  ionized  calcium  directly 
suppresses the PTH secretion by activating parathyroid calcium 
sensing  receptors  (CaSRs).   Also  ionized  calcium  indirectly 
affects PTH secretion via effects on 1,25-dihydroxycholecalciferol 
production.  This  active  vitamin  D  metabolite  inhibits  PTH 
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production by an incomplete understood mechanism of negative 
feedback. 
Even slightest decrease in the calcium ion concentration in 
extracellular fluid caused the parathyroid glands to increase their 
rate  of  secretion  within  minutes.  The  PTH  stimulates  enough 
calcium absorption from the bones to maintain a normal plasma 
ion  concentration.  Conversely  the  conditions  that  increase  the 
serum ionized calcium lead to decrease in PTH secretion.
Calcium in vascular tone regulation:
The vascular smooth muscle cells contract when stimulated 
by rise  in intracellular  calcium concentration by calcium influx 
through  the  plasma  membrane  and  calcium  release  from 
intracellular  stores.  In  vascular  smooth  muscle  cells,  voltage  – 
dependent  L-type  calcium  channels  open  with  membrane 
depolarization,  which  is  regulated  by  energy  –  dependent  ion 
pumps such as Na+K+-ATPase and ion channels such as the Ca2+ 
sensitive K + channels. Local changes in the intracellular calcium 
concentration, termed as calcium sparks, results from the influx of 
calcium through the voltage- dependent calcium channel and are 
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caused by the co-ordinated activation of a cluster of ryanodine-
sensitive calcium release channels in the sarcoplasmic reticulum. 
The calcium sparks lead to a further direct increase in intracellular 
calcium concentration. 
Vascular  smooth  muscle  cell  contraction  is  principally 
controlled by  the  phosphorylation of  myosin light  chain kinase 
and myosin light chain phosphatase. Myosin light chain kinase is 
activated by calcium through the formation of calcium-calmodulin 
complex; with the phosphorylation of myosin light chain by this 
kinase,  the  myosin  ATPase  activity  increased  and  contraction 
sustained.  Myosin  light  chain  phosphatase  dephosphorylates 
myosin  light  chain,  reducing  myosin  ATPase  activity  and 
contractile force.
The role of calcium in pregnancy induced hypertension:
Abnormalities in Calcium homeostasis may contribute to the 
increased  vascular  sensitivity  in  preeclampsia.  Calcium 
metabolism  is  under  strain  during  pregnancy.  The  daily 
requirement  of  calcium  during  pregnancy  is  1200mg.  The 
expectant mothers need to store about 30-50gm of calcium during 
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the course  of  pregnancy, of  which 25gms are  needed by fetus. 
Eighty  percent  of  total  fetal  calcium  is  deposited  during  third 
trimester.  The transport  of  ionized calcium from the  mother  to 
fetus increases from about 50mg/day at 20 weeks of gestation to 
maximum of about 350mg/day at 35 weeks of gestation Forkes 
GB 1976.  Maternal  total  serum calcium levels  decrease  during 
pregnancy, with a nadir at 28 to 32 weeks related to decrease in 
albumin levels that accompany the increase in vascular volume.
Decreased  serum  calcium  levels  lead  to  an  increase  in 
parathyroid  hormone  levels,  thereby  increasing  the  intracellular 
calcium levels, which leads to an increase in the vascular smooth 
muscle  contraction  and thus  an  increase  in  the  blood pressure. 
Despite low circulating calcium levels, the intracellular calcium 
ions are high which leads to hypertension Belizan et al. 1988.
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THE MAGNESIUM
Introduction:
Magnesium is the fourth most abundant and the second most 
prevalent  intracellular  divalent  cation. Magnesium is  a  cofactor 
for more than 300 enzymes in the body. It is required for enzyme 
substrate  formation  (Mg++ATP).  In  addition  magnesium  is  an 
allosteric activator of many enzyme systems. Magnesium plays an 
important  role  in  oxidative  phosphorylation,  glycolysis,  cell 
replication, nucleotide metabolism and protein biosynthesis. 
Intracellular magnesium forms a key complex with ATP and 
is important cofactor for a wide range of enzymes, transporters 
and nucleic acid required for normal cellular function, replication 
and  energy  metabolism.  Extracellular  magnesium  provides  for 
maintenance  of  intracellular  magnesium.  Reduction  in  serum 
magnesium  concentration  results  in  increased  neuromuscular 
excitability because magnesium competitively inhibits the entry of 
calcium into neurons.
4
The total  body magnesium is 25mg.  The concentration of 
serum magnesium is 1.7- 2.4 mg/dl (1.5 – 2 mEq/L, 0.7-1.0 mmol/
L) Harrison Principles of Internal Medicine 17th edition. 
Approximately  55%  of  total  body  magnesium  is  in  the 
skeleton.  The extra  cellular  magnesium accounts for  1% of  the 
total  magnesium content.  The remainder is  intracellular.  Within 
the cell, magnesium is bound primarily to proteins and negatively 
charged molecules. 80% of cytosolic magnesium is bound to ATP. 
Approximately 0.5- 5% is free,  which is the fraction that alters 
enzyme activity.
In serum about 55% of magnesium is free 30% is associated 
with  proteins  primarily  albumin  and  15% forms  complex  with 
phosphate, citrate and other anions.
The  role  of  magnesium  in  pregnancy  induced 
hypertension:
The daily  requirement of  magnesium during pregnancy is 
310mg.  The  hypomagnesemia  in  most  pregnant  women  is 
associated with hemodilution,  renal  clearance during pregnancy 
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and consumption of minerals by the growing fetus Chanvitya et 
al, 2008.
Magnesium deficiency causes hemodynamic abnormalities 
such  as  arterial  wall  thickening,  abnormal  vascular  tone  and 
endothelial dysfunction which are due to alteration in the biology 
of  cellular  and noncellular  components  of  arterial  wall  Shalini 
Maksane et al, 2011.
The role  of  Magnesium appears  to  be  associated with its 
function  as  an  activator  of  enzymes  involved  in  membrane 
transport and integrity and with its relationship to prostaglandins- 
specifically,  the  ratio  of  prostacyclins  (vasodilators)  and 
thromboxane  (some  of  which  are  vasoconstrictors),  which  is 
dramatically altered in the case of low serum magnesium. Both 
the  prostacyclins  and  thromboxane  substances  are  increased 
during  a  normal  pregnancy.  However,  women  who  develop 
preeclampsia  have  a  much  smaller  increase  in  prostacycline 
production  than  other  pregnant  women,  while  thromboxane 
continue to rise at the same rate, thus increasing vasoconstriction 
and rising blood pressure  M Zakir H Howlader et al, 2009. In 
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addition magnesium depletion increases the vasoconstrictor effect 
of angiotensin II and adrenaline Indumati et al, 2011.
Magnesium  works  as  a  natural  calcium  channel  blocker. 
Magnesium is the physiological antagonist of calcium Fawett et 
al,  1999.  It  has  been  postulated  that  if  the  concentration  of 
extracellular magnesium is lowered, calcium influx is enhanced. 
Magnesium  acts  by  opposing  calcium  dependent  arterial 
constriction and may also antagonize the increase in intracellular 
calcium concentration Kumuru et al, 2003.
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THE ZINC
Introduction:
The  zinc  is  second  to  Iron  as  the  most  abundant  trace 
element in the body. It  is  an integral  component  of nearly 300 
enzymes  in  different  species  of  all  phyla.  The  important  zinc 
containing metalloenzymes in human include carbonic anhydrase, 
alkaline  phosphatase,  RNA  and  DNA  polymerases,  thymidine 
kinase,  carboxypeptidases and alcohol  dehydrogenase.  The zinc 
atoms  firmly  bound  to  the  active  site  of  the  metalloprotein 
molecule  to  contribute  to  the  conformational  and  structural 
stability of metalloenzymes.
The zinc plays a major role in protein synthesis and has an 
important function in gene expression, the involvement in gene 
expression  is  both  a  structural  and  an  enzymatic  role.  Metal 
binding  by  DNA  and  RNA  affects  the  chemical  and  physical 
properties of the macromolecules in ways that may be related to 
replication and protein synthesis. Thymidine kinase and various 
DNA and RNA polymerase require Zinc for their activity Magri 
et al, Kumru et al, 2003. Zinc finger proteins bind to the specific 
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domain of DNA molecule. These proteins require zinc for their 
conformation and DNA binding abilities.
In addition to its roles in catalysis and gene expression, zinc 
stabilizes the structures of proteins and nucleic acid, preserves the 
integrity  of  subcellular  organelles,  participates  in  transport 
processes,  and  has  important  role  in  viral  and  immune 
phenomenon. 
The zinc is an important element in wound healing. Several 
studies  have  implicated  zinc  as  a  necessary  factor  in  the 
biosynthesis and integrity of connective tissue. Zinc is absolutely 
required for normal spermatogenesis, fetal growth and embryonic 
development.
The normal serum Zinc concentration ranges from 75-120 
µg/dl (11.5-18.4 µmol/L). Zinc is transported in blood mainly by 
albumin 60-70%, α2 macroglobulin 30-40% and a small amount 
through transferrin and free amino acids.  The diagnosis of zinc 
deficiency is usually made when serum zinc level of < 70 µg/dl.
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Physiological  basis  of  zinc  in  pregnancy  induced 
hypertension:      
During pregnancy there is a decline in circulating zinc and 
this increase as the pregnancy progresses possibly due to increase 
in blood volume and decrease in zinc binding and an increase in 
transfer of zinc from mother to fetus Tamura et al, 2000. Zinc is 
shifted  from  the  plasma  to  Red  corpuscles.  The  normal 
requirement of Zinc during pregnancy is 12mg/day.
Zinc  has  been reported to  play a  role  in  hypertension by 
exerting an inhibitory effect  on ATP- dependent  calcium pump 
that catalyzes the movement of calcium ions.  Low extracellular 
zinc  concentration  favours  the  inflow  and  accumulation  of 
calcium  ion  in  the  cells,  leading  to  increased  vasoconstriction 
Tubek S, 2007.
In  vascular  cells  reactive  oxygen  species  (ROS)  are 
produced by NADPH oxidases, uncoupled nitric oxide synthase, 
xanthine  oxidase  and  by  mitochondrial  sources.  The  reactive 
oxygen species might cause hypertension because the increased 
O2.- radical oxidize NO to peroxynitrite and subsequently to nitrite 
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and  nitrate.  This  results  in  a  loss  of  bioactive  NO-mediated 
vasodilatation,  an increase in vasoconstriction and subsequently 
an  increase  in  systemic  vascular  resistance,  raising  the  blood 
pressure.
Zinc has antioxidant property by the following ways
(1) A  zinc  containing  enzyme,  superoxide  dismutase  causes 
dismutation of O2.- by conversion to hydrogen peroxide Aggett 
PJ, 1985.
(2) Zinc  can induce  the  production  of  metallothionein which is 
very  rich  in  cysteine  and  is  an  excellent  scavenger  of  free 
radical OH.. 
(3) The enzyme NADPH oxidases which catalyze the production 
of free radicals from oxygen is inhibited by zinc  Prasad AS, 
2008.
Zinc  deficiency  impairs  taste  leading  to  an  unwilling 
increase in salt consumption that is a known predisposing factor 
for hypertension Chiplonkar et al, 2004.
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MATERIALS AND METHODS
This is a cross sectional case - control study conducted in 
the Department of Obstetrics & Gynecology, Government Rajaji 
Hospital, Madurai during the period from 20/6/2011 to 20/8/2011.
The Ethical  and Research committee of  Madurai  Medical 
College and Hospital approved the study protocol.
Participants:
The  study  was  conducted  in  50  pregnant  women  of  age 
group between 20 – 40 years. Of them, case group comprised of 
25  pregnant  women  either  primi  or  second  gravida  in  third 
trimester (> 24 weeks of pregnancy) with preeclampsia admitted 
as in patients in Department of Obstetrics and Gynecology.
The diagnosis of preeclampsia was based on clinical criteria 
with blood pressure ≥ 140/90mmHg measured on two occasions 6 
hours  apart  with  proteinuria  ≥1+  dipstick  along  with  edema 
(NHBPEP Classification).
The  control  group  was  formed  by  25  normal  pregnant 
women  either  primi  or  second  gravida  in  third  trimester  >  24 
weeks of pregnancy receiving antenatal care as out patients.
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Exclusion criteria used for selecting participants:
Medical complicating pregnancy such as Diabetes Mellitus, 
Renal  failure,  Chronic  hypertension,  Heart  failure,  Multiple 
pregnancies and Pregnancy ≤ 24 weeks of gestation. Patients on 
magnesium sulphate and calcium lactate  therapy were excluded 
from study.
Permission for conducting the study was obtained from The 
Dean, Madurai Medical College, The superintendent, Government 
Rajaji Hospital and from the Head of the Department, Obstetrics 
and Gynecology, Rajaji Hospital, Madurai.
Written  consent  was  obtained  from  the  participants  after 
explaining the aim and methods of the project. The proforma was 
prepared and filled during the visit.
After  filling  the  proforma  the  participants  underwent  a 
general examination and obstetrical examination, which consisted 
of fundal height, presenting part and fetal heart rate.
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Examination of pedal edema:
A firm pressure was applied over the medial malleolus on 
both legs for 15 seconds in all participants and looked for pitting 
in that region to confirm the presence of pedal edema.
Anthropometry:
The  heights  of  the  participants  were  measured  using 
standard methodology with the help of non-stretchable inch tape. 
The weights of the participants were measured using a weighing 
machine and BMI was calculated using Quetlet Index using the 
formula Wt (kg)/ht (mt)2.
Measurement of Blood pressure:
With  a  standard  sphygmomanometer  and  stethoscope  the 
systolic  and  diastolic  blood  pressure  of  all  participants  were 
measured in the right upper arm in sitting posture by Auscultatory 
method. The first  and fifth Korotkoff’s phase were recorded as 
systolic  and  diastolic  blood  pressure  respectively.  The  blood 
pressure for  cases group was recorded at  two occasions one at 
9.00 Am and another at 5.00 Pm using the same procedure.
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Estimation of urine albumin:
Clean catch midstream random urine sample was obtained 
from all participants. The urine protein was measured by dipstick 
method using Dip N Read reagent strip. The results was graded on 
the scale of 0 to 4+ (0, none; 1+, 30 mg/dl; 2+, 100 mg/dl; 3+, 300 
– 1,999 mg/dl; 4+ ≥ 2000 mg/dl).
Blood sample collection:
Three ml of blood was drawn in all the participants from the 
cubital vein by using dispovan. The blood drawn was collected in 
a vaccum tube.
Estimation of Hemoglobin:
From the collected blood 0.02ml of the whole blood was 
used for hemoglobin estimation by Sahli’s acid hematin method 
using hemoglobinometer.
Serum separation:
The blood samples were allowed to clot  spontaneously at 
the room temperature. Then the clotted blood was centrifuged at 
3,000rpm for 10 minutes. The serum separated was stored at 2 - 8 
degrees Celsius until analysis.
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Estimation of Calcium:
 A part of serum was used for estimation of calcium.
Method: 
Spectrophotometric  method  using  O-cresolpthalein- 
complexone as colour indicator.
Principle: 
In  alkaline  solution,  calcium  binds  with  metal  complex 
O-Cresopthalein  complexone  (OCPC)  to  form a  bluish-  purple 
Complex, which is measured at 578nm. The intensity of colour is 
proportional  to  the  calcium  concentration  in  the  sample. 
Hydroxyquinoline  acts  as  a  masking  agent  and  eliminates  the 
interference of magnesium.
 Calcium + OCPC                                   Bluish + purple complex.
Reagents:
R 1 OCPC Reagent O-Cresolpthalein 
complexone
Hydrochloric Acid
8-Hydroxyquinoline
0.16  mM/
L
50 mM/L
17 mM/L
R 2 AMP Buffer 2  Amino  3  methyl 
propanol
500 mM/L
R 3 Calcium Standard Calcium 10 mg/dl
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Working reagent preparation:
Reagent 1 was diluted with Reagent 2 in equal proportion (1 
ml of Reagent  1 + 1 ml of  Reagent 2) and mixed properly by 
gentle swirling.
Stability: Working reagent is stable for 15 days at 2 - 80 C.
Procedure:
Pipette into vials Blank Standard Test
Serum - - 20µl
Calcium Standard - 20µl -
Working reagent 1000µl 1000µl 1000µl
Reagents  were  mixed  well  and  incubated  at  37oC  for  5 
minutes.  The  analyzer  was  blanked  with  reagent  blank.  The 
absorbance was measured at 578nm first for the standard sample 
followed  by  test  sample.  The  result  was  calculated  using  the 
formula.
Calculation:
               Absorbance of Test     
 Serum Calcium (mg/dl)      =                  x 10
                                               Absorbance of standard 
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Estimation of Serum Magnesium:
A part of serum was used for serum magnesium estimation.
Method:  Calmagite method.
Principle: 
Magnesium combines with calmagite in an alkaline medium 
to form a red colour complex. Interference of calcium and proteins 
are eliminated by adding specific chelating agents and detergents. 
Intensity  of  the  colour  formed  is  directly  proportional  to  the 
amount of magnesium present in the sample.
    Magnesium + calmagite                          Red coloured complex
Reagents:
R 1 Calmagite
Potasium Chloride
Polyvinylpyrrolidine
0.14 mM/L
77 mM/L
0.03 mM/L
R 2 Potasium cyanide
Potassium Hydroxide
1.5 mM/L
14.3 mM/L
S Magnesium standard 2.0 mEq/L
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Working reagent:
Working reagent was prepared by mixing the equal volume 
of R 1 and R 2.
Stability: The working reagent is stable at 2 - 80 C for one month.
Procedure:
Pipette into 
vials
Blank (B) 
ml
Standard (S) 
ml
Test (T) 
ml
Serum 0.01
Magnesium 
standard
0.01 ml
Working Reagent 1 ml
Distilled water 0.01 ml
The reagents were pipetted into clean dry test tube. Mixed 
well and incubated at room temperature (250 C) for 5 minutes. The 
absorbance  was  measured  in  analyzer  at  510  nm  first  with 
standard against blank sample and then for the test sample against 
blank sample.
Calculation:
   Absorbance of test          
   Magnesium in mmol/L    =    x 2
Absorbance of standard
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Conversion factor:
  Magnesium concentration mg/dl = Mg concentration mmol/L X 2.43
Estimation of serum Zinc:
A part of serum was used for serum magnesium estimation.
Method: Calorimetric method
Principle:
Zinc in an alkaline medium reacts with 5 – Br – Paps to 
form a purple coloured complex. Intensity of the complex formed 
is  directly  proportional  to  the  amount  of  zinc  present  in  the 
sample.
Zinc + 5 – Br- Paps                            Purple coloured complex
Reagents:
R 1 5 – Br- Paps
Sodium citrate
Dimethylglyoxime
Bicarbonate buffer
0.07mM/L
170 mM/L
4 mM/L
0.2 Mol/L
R 2 Salicyaldoxime 29 mM/L
S Zinc Standard 200 µg/dl
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Working Reagent:
Working reagents were prepared from mixing together four 
parts of R 1 and one part of R2.
Stability:  The  working  reagent  is  stable  upto  2  days  at  room 
temperature (below 350 C) or for one week at 2 - 100 C.
Procedure:
Pipette into vials Blank 
(B) ml
Standard (S) Ml Test (T) 
ml
Serum 0.05
Zinc Standard 0.05
Working reagent 1.0 1.0 1.0
Distilled water 0.05
The reagents were pipetted into clean dry test tubes. Mixed 
well  and  incubated  at  room  temperature  for  5  minutes.  The 
absorbance  was  measured  in  an  analyzer  at  578  nm first  with 
standard  sample  against  the  blank  and  then  with  test  sample 
against the blank. 
Calculation:
      Absorbance of Test          
Zinc in µgm/dl       =     x 200     
 Absorbance of standard
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RESULTS AND OBSERVATIONS
Summary of the Study
Contents Cases (n=25)
(mean±SD)
Controls 
(n=25)
(mean±SD)
p-
value
Age (yrs) 23.80±3.48 23.52±2.52 0.746
BMI (kg/m2) 28.71±4.70 22.46±3.42 <0.001
Gravida 1.480 ±0.51 1.52± 0.510 0.783
Parity 0.48 ±0.510 0.520 ±0.510 0.783
Weeks of 
gestation (Wks)
32.56±4.34 32.56±3.48 1.000
Pulse (/min) 97.36±8.56 94.16±10.59 0.246
Systolic BP 
(mmHg)
157.2±14.29 101.04±9.47 <0.001
Diastolic BP 
(mmHg)
100.8±7.59 68.0±6.45 <0.001
Hb (gm %) 10.32±1.45 10.36±1.08 0.912
Serum Calcium 
(mg/dl)
8.07±0.43 8.96±0.59 <0.001
Serum 
Magnesium 
(mg/dl)
1.62±0.16 1.92±0.16 <0.001
Serum Zinc 
(µg/dl)
80.6±9.78 93.28±9.44 <0.001
p-value < 0.05 is significant.
5
Table -1
Comparison of BMI between the preeclamptic women and 
normal pregnant women
Contents Cases Controls
  Mean S.D    Mean S.D
BMI 28.71 4.70 22.46 3.42
P < 0.001
From the above result it is evident that p value is significant 
and the BMI of preeclamptic women is significantly higher than 
that of the normal pregnant women.
Table – 2
Comparison of pulse rate between the cases and the controls
Content Cases Controls
Mean S.D Mean S.D
Pulse 97.36 8.58 94.16 10.59
P value = 0.246
          From the above result it is evident that the p value is not 
significant and there is no significant difference in the pulse rate 
between the cases and the controls.
6
Table-3
Comparison of Systolic Blood Pressure between the 
preeclamptic women and the normal pregnant women
Content Cases Controls
Mean SD Mean SD
Systolic Blood 
Pressure  (mmHg)
157.2 14.2
9
101.04 9.47
P Value < 0.001                
From  the  above  results  it  is  clear  that  the  p  value  is 
significant and there is a significant increase in systolic pressure in 
the  preeclamptic  women  compared  to  the  normal  pregnant 
women.
Table- 4
Comparison of Diastolic Blood pressure between the cases and 
the controls
Contents Cases Control
Mean SD Mean SD
Diastolic Blood 
pressure (mmHg)
100.8 7.59 68.0 6.45
P value < 0.001  
          From the above results it is clear that there is a significant 
increase in diastolic blood pressure in the cases when compared to 
the controls.
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Table – 5
Comparison of Hemoglobin between the preeclamptic 
and the normal pregnant women
Content Cases Controls
Mean S.D Mean S.D
Hemoglobin 10.32 1.45 10.36 1.08
P value = 0.912         
From the above results it is evident that there is no significant 
difference  in  the  hemoglobin  levels  between  the  cases  and  the 
controls.
Table - 6
Comparison of serum calcium levels between the preeclamptic 
women and normal pregnant women
Content Cases Controls
Mean      S.D Mean     SD
Serum Calcium 
(mg/dl)
8.07 0.43 8.96     0.59
P value < 0.001
      The normal serum calcium concentration is 8.5 – 10.5 mg/dl. 
From  the  above  results  it  is  evident  that  there  is  a  significant 
decrease in the level of serum calcium in the preeclamptic women 
when compared with the normal pregnant women. 
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Table – 7
Comparison of the serum Magnesium levels between the 
preeclamptic women and the normal pregnant women
Content Cases Controls
Mean SD Mean     SD
Serum Magnesium 
(mg/dl)
1.62     0.16 1.92    0.16
P value < 0.001
The normal serum magnesium concentration is 1.7–2.4mg/dl. 
From the above results it is clear that there is a significant decrease 
in the level of serum magnesium in the women with preeclampsia 
compared with the normal pregnant women.
Table – 8
Comparison of the serum zinc levels between the preeclamptic 
and the normal pregnant women
Contents Cases Controls
Mean     SD Mean      SD
Serum zinc         (µg/
dl)
80.7 9.78 93.28 9.44
P value < 0.001
The normal serum zinc concentration ranges from 75-120mg/
dl. From the above results it is evident that there is a significant 
decrease in the level of serum zinc in the women with preeclampsia 
compared with the normal pregnant women.
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Statistical Analysis:
The comparison between the cases and controls was done by 
using one - way ANOVA test using SPSS (Statistical Package for 
Social Science) software, Sigma stat version 3.5. The significance 
was drawn at p value (probability) of < 0.05. 
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DISCUSSION
The changes in the levels of serum calcium, magnesium and 
zinc  in  preeclamptic  women  compared  to  the  normal  pregnant 
women were studied by several other investigators.
In the present study the Body Mass Index of preeclamptic 
women is significantly  higher than that  of  the normal pregnant 
women.  These  findings  are  in  agreement  with  the  studies  of 
Chanvitya punthumapol  et  al,  2008.  Akinloye et  al,  2010  in 
their study showed that there was no significant difference in the 
BMI between the preeclamptic and the normal pregnant women. 
In 2001, Pipkin in his study showed that the women with higher 
BMI become hypertensive than those with lower BMI.
In  this  study  there  is  a  significant  decrease  in  the  serum 
calcium levels in the preeclamptic women when compared to the 
normal pregnant women.
The data supported that the lowered calcium levels might be 
a  cause  in  the  development  of  preeclampsia.  The  effect  of  the 
serum calcium on  the  changes  in  the  blood  pressure  could  be 
explained by the level of intracellular concentration of calcium. 
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The increase in the intracellular calcium concentration when the 
serum calcium level went lower lead to constriction of the smooth 
muscles in blood vessels and an increase in vascular resistance.
Abdelmarouf H. Mohielden et  al,  2007 showed in their 
studies that the mean calcium concentration in the preeclampsia 
group is significantly lower than the normal pregnant women.
Several  studies  had  examined  the  effects  of  the  calcium 
supplementation  on  blood  pressure  during  pregnancy  thus 
investigating the role of calcium supplementation and its effects 
on blood pressure. In 1996, Bucher HC et al  conducted a meta- 
analysis of randomized controlled trials on the effect of calcium 
supplementation  on  preeclampsia.  They  concluded  that  the 
supplementation  during  pregnancy  leads  to  a  reduction  in  both 
systolic and diastolic blood pressure and preeclampsia.
In  the present  study there  is  a  significant  decrease  in  the 
mean  serum  magnesium  concentration  in  preeclamtic  women 
compared to the normal pregnant women.
Serum  magnesium  levels  have  significant  effects  on  the 
cardiac  excitability  and  reactivity.  Magnesium,  as  a  calcium 
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antagonist promotes vascular smooth muscle relaxation. Thus the 
low levels  of  magnesium predispose  to  increase  in  the  arterial 
pressure.
The studies of Idogun et al, 2007 and Indumati et al, 2010 
showed that  the  serum calcium level  and  magnesium levels  in 
preeclamptic pregnant women is significantly lower than that of 
the normal pregnant women.
In  2008,  Chanvitya  et  al,  in  his  study  revealed  that  the 
serum  calcium  level  was  lower  in  preeclamptic  women  when 
compared  with  the  normal  pregnant  women  but  there  was  no 
difference in the serum magnesium levels.
In  this  study there  is  a  decrease  in  the  mean serum Zinc 
levels in preeclampsia when compared to the controls. This result 
is contradictory with the studies conducted by Harma et al, 2005 
in turkey and Diez et al, 2002  who showed that the serum zinc 
levels  in  preeclamptics  was  higher  than  that  in  the  normal 
pregnant women.
The  result  of  this  current  study is  in  agreement  with  the 
studies  of  Muhammed  ashraf  et  al,  2007  and  Parbin 
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Bahadoran et al, 2010  who showed that there was a significant 
decrease in serum zinc levels in preeclampsia group compared to 
normal pregnancy. In 2010, Emmanuel I. Ugwuja et al, in their 
study showed that there was no significant decrease in the serum 
zinc levels in preeclamsia.
Zinc  insufficiency  has  been  recognized  by  a  number  of 
experts  as  an  important  public  health  issue  especially  in 
developing  countries.  During  pregnancy  the  decrease  in  the 
circulating zinc is possibly due to increased transfer of zinc from 
mother  to  the  fetus  and  due  to  plasma  expansion.  Zinc  is  a 
metallic  component  of  enzyme  superoxide  dismutase,  which 
causes protection from damage by free radical. The hypozinemia 
suppressing  the  activity  of  superoxide  dismutase  may  be  a 
precipitating factor for preeclampsia.
There  was  no  significant  decrease  in  the  mean  serum 
calcium, magnesium and zinc levels between the preeclamptic and 
the  normal  pregnant  women  in  the  studies  conducted  by 
Golmohammed et al, 2008.
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Studies  by  Jain  S  et  al,  2010 showed  that  there  was  a 
significant reduction in the levels of serum calcium, magnesium 
and  zinc  in  the  patient  with  preeclampsia  compared  with  the 
normal pregnant women.
Further in the present study no significant correlation could 
be made between levels of serum calcium, magnesium and zinc 
and the severity of preeclampsia. 
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CONCLUSION
In this study the serum levels of calcium, magnesium and 
zinc is compared between 25 women with preeclampsia with 25 
normal pregnant women in third trimester of the pregnancy.
This study has shown that the serum calcium, magnesium 
and zinc levels in preeclampsia are significantly lower than the 
normal pregnant women with p value < 0.001.
From the above study, though the calcium, magnesium and 
zinc deficiencies cannot be pinpointed as the sole factors for the 
aetiology  of  preeclampsia,  they  have  a  definite  role  in  the 
development of preeclampsia.
Decrease in the extracellular calcium level causes increased 
intracellular calcium through parathyroid hormone. This leads to 
an  increase  in  vascular  smooth  muscle  contraction  and  thus 
increases  the  blood  pressure.  Magnesium  as  a  physiological 
antagonist  of  calcium,  antagonizes  the  increase  in  intracellular 
calcium concentration and decreases the vascular smooth muscle 
contraction. Zinc by its antioxidant property and inhibitory effect 
on ATP dependent calcium pump decrease the vascular smooth 
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muscle contraction there by decreasing the blood pressure. Hence 
decrease in these elements is a predisposing factor for pregnancy 
induced hypertension.
Therefore  the  calcium,  magnesium and  zinc  consumption 
should be encouraged during the second and third trimesters of 
pregnancy. The dietary supplements of calcium, magnesium and 
zinc  in  the  form  of  milk,  cheese,  soya  bean  products,  leafy 
vegetables etc., during pregnancy could result in the reduction of 
incidence of preeclampsia. The direct supplementation therapy of 
these  elements  can  be  considered  for  the  women  with 
preeclampsia to ensure the child survival and the safe motherhood.
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PROFORMA
Serial No.:                                                             Date:
Name : Age    : Sex:
Address :
Height : Weight: BMI:
     Medical H/o :  Diabetic / Heart Disease / Asthmatic / Renal failure / 
                         Under any medication
Family H/o :  Hypertension /Diabetes Mellitus / Pre-eclampsia
Marital H/o :
Menstrual H/o :
Previous Obstetric H/O :
Gravida :
     LMP : EDD: Weeks of Gestation:
On Examination:
Odema: Present/ Absent
Pulse :
BP :   Systolic:                  Diastolic:
Obstetrical Examination:
Fundal Height: Presentation: Fetal heart rate:
Investigations:
     Blood:                  Urine :
Hb% :                      Urine Al :
Serum Calcium :
Serum Magnesium :
Serum Zinc :
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Figure-1 
Comparison of BMI between the preeclamptic women and 
normal pregnant women
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Figure-2 
Comparison of pulse rate between the cases and the controls
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Figure-3 
Comparison of Systolic Blood Pressure between the preeclamptic 
women and the normal pregnant women
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Figure-4 
Comparison of Diastolic Blood pressure between the 
Cases and the controls
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Figure-5 
Comparison of Hemoglobin between the preeclamptic and 
the normal pregnant women
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Figure-6 
Comparison of serum calcium levels between the preeclamptic 
women and normal pregnant women
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Figure-7 
Comparison of the serum Magnesium levels between the 
preeclamptic women and the normal pregnant women
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Figure-8 
Comparison of the serum zinc levels between the preeclamptic 
and the normal pregnant women
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EARLY DEVELOPMENT OF PLACENTA
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1 26 23.37 2 1 32 90 100 70 Nil 10.8 7.9 2.1 96
2 20 26.88 1 0 36 100 100 70 Nil 10.2 8 1.9 98
3 25 22.22 1 0 29 76 90 70 Nil 9.4 8.5 1.9 88
4 20 20.73 2 1 32 74 110 70 Nil 10.6 8.8 1.9 94
5 23 23.81 2 1 38 96 100 80 Nil 11.4 9.7 1.9 93
6 27 22.04 2 1 31 90 90 60 Nil 12.2 10.1 1.8 89
7 27 23.31 1 0 35 110 100 70 Nil 11.8 9.9 2.1 97
8 25 19.1 1 0 35 82 100 60 Nil 9.8 8.6 2 101
9 22 23.6 1 0 38 84 90 70 Nil 11.6 9.2 2.2 74
10 20 17.48 1 0 27 102 90 60 Nil 9.2 9 2.1 104
11 25 23.01 1 0 33 106 100 70 Nil 9.8 9.6 1.5 93
12 21 25.44 1 0 36 100 110 70 Nil 11.6 8.8 2 111
13 26 21.5 2 1 37 90 90 60 Nil 11.8 8.8 1.8 90
14 21 19.82 1 0 33 102 120 70 Nil 8.2 8.8 1.9 96
15 25 24.14 2 1 34 90 100 60 Nil 11.2 9 2 101
16 29 21.93 2 1 29 98 90 70 Nil 8.8 8 1.8 103
17 21 23.44 2 1 29 106 110 60 Nil 9.6 9 1.9 86
18 24 18.59 2 1 35 84 100 70 Nil 10.8 8.7 2.1 106
19 22 19.53 1 0 34 102 110 70 Nil 11.6 9.5 1.9 91
20 22 22 2 1 34 96 112 80 Nil 9.2 9.6 1.7 74
21 25 35.17 2 1 31 100 120 80 Nil 10.6 9.2 1.8 88
22 25 19.34 1 0 34 104 100 60 Nil 9.8 8.1 2 102
23 22 21.85 1 0 27 80 90 70 Nil 10.2 9 1.7 92
24 21 21.64 2 1 29 110 110 70 Nil 9.4 8.8 2.1 76
25 24 21.64 2 1 26 82 94 60 Nil 9.8 9.4 1.9 89
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1 30 31.58 1 0 33 98 160 90  ++ 10.8 7.9 1.9 88
2 20 29.73 1 0 34 90 150 90  ++ 12 8.1 1.4 95
3 25 29.28 1 0 28 100 200 100  +++ 10.2 8.4 1.6 68
4 25 31.96 2 1 36 100 140 90  ++ 10.8 8.9 1.6 86
5 22 28.68 1 0 36 100 140 90  ++ 8.4 7.9 1.6 96
6 22 22.31 1 0 39 96 140 110  ++ 11.4 7.4 1.8 97
7 26 43.9 2 1 35 98 150 90  ++ 9.4 8.4 1.6 88
8 28 21.7 2 1 29 82 150 110  ++ 9.2 7.6 1.8 96
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10 23 29.9 2 1 35 82 170 100  ++ 10.8 7.9 1.8 81
11 20 33.2 1 0 36 88 150 110  ++ 11 8.9 1.5 87
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23 22 25.44 2 1 31 108 160 100  ++ 10.8 8.8 1.6 82
24 22 23.44 2 1 32 110 150 100  ++ 11.6 8.1 1.6 90
25 21 24.14 2 1 32 104 170 100  ++ 11.8 7.8 1.5 74
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